Format

Send to

Choose Destination
Nat Rev Cancer. 2014 Nov;14(11):709-21. doi: 10.1038/nrc3803.

Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?

Author information

1
Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.

Abstract

Mitochondria cooperate with their host cells by contributing to bioenergetics, metabolism, biosynthesis, and cell death or survival functions. Reactive oxygen species (ROS) generated by mitochondria participate in stress signalling in normal cells but also contribute to the initiation of nuclear or mitochondrial DNA mutations that promote neoplastic transformation. In cancer cells, mitochondrial ROS amplify the tumorigenic phenotype and accelerate the accumulation of additional mutations that lead to metastatic behaviour. As mitochondria carry out important functions in normal cells, disabling their function is not a feasible therapy for cancer. However, ROS signalling contributes to proliferation and survival in many cancers, so the targeted disruption of mitochondria-to-cell redox communication represents a promising avenue for future therapy.

PMID:
25342630
PMCID:
PMC4657553
DOI:
10.1038/nrc3803
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center